RCS - Aster DM - 2023 Grand Jury Announced for Aster Guardians

Aster DM HealthcareAnnouncement

20/03/2023 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230320:nRST5446Ta&default-theme=true

RNS Number : 5446T  Aster DM  20 March 2023

2023 Grand Jury Announced for Aster Guardians Global Nursing Award

The Solo Winner's Prize Fund Totals $250,000

·      Aster DM Healthcare's 'Aster Guardians Global Nursing Award'
(https://pr.report/7AuDxBSQ) is one of the world's most prestigious awards in
nursing carrying with it the highest prize money of USD 250,000 to be won by
one nurse.

·      Over 52,000 registrations have been received from nurses from 202
countries; a 116% growth from the 1st edition of the award of 2022 which
received 24,000 registrations.

·      Aster Guardians Global Nursing Award 2023 will be held on
International Nurses Day (12(th) May, 2023), at the Queen Elizabeth II Centre
in London (https://pr.report/RrXYje6G)

LONDON, UK / ACCESSWIRE / March 20, 2023 / Speaking on this year's entries,
Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare
who is based in Dubai said:

To view image, please click here
(https://www.accesswire.com/users/newswire/images/744615/grand-jury-for-aggna-2023.jpg)
.

"We are extremely excited to see the overwhelming response that the initiative
has received from nurses across the world. With over 52,000 registrations from
over 202 countries for the second edition of the Award, it will be a daunting
task for the Jury to decide the winner this year.

He added: They have started the review process and shall present the top 10
finalists soon. These finalists will then undergo a public voting process and
Q&A interaction with the Grand Jury for the final winner to be
determined."

The 2023 Grand Jury consists of six leading experts in healthcare and nursing:

Dr. Peter Carter, an OBE awardee (Officer of the Order of the British Empire),
an independent healthcare consultant and former CEO of the Royal College of
Nursing; Mr. Howard Catton - Chief Executive Officer, International Council of
Nurses, Switzerland; Prof. Sheila Tlou - Co-Chairperson, Global HIV Prevention
Coalition and Ex - Minister of Health & Member of Parliament - Govt. of
Botswana; Prof. James Buchan - Adjunct Professor, WHO Collaborating Centre for
Nursing; Dr. J Carolyn Gomes, Vice-Chair of the Strategy Committee - The
Global Fund Board and Board Member of The Developing Country NGO Delegation to
the GF Board; and Dr. Niti Pall -Senior Digital Advisor for AXA (EC), she is
also Board Chair of Harbr and Managing Director of Health4all advisory. In
addition Dr. Niti is a senior doctor with deep expertise in digital health
innovation.

Anna Qabale Duba, the recipient of the inaugural Aster Guardians Global
Nursing Awards in 2022, said, "As nurses, we have the chance to heal our
patients -hearts, minds, and bodies. It is truly a very rewarding experience
to be able to help people who need assistance, and sometimes, these stories
are worth sharing with the world. Aster Guardians Global Nursing Award is one
such initiative which is bringing forth these stories and giving nurses like
us a chance to share them on a global platform."

Mr. Howard Catton, CEO of the International Council of Nurses (ICN) is a
strong advocate for nurse leadership and is committed to ensuring that ICN and
its network of National Nurses Associations work to put nurses at the centre
of our health systems.

Professor Sheila Tlou has played a key role in the development of national
nursing and medical education programs throughout her career. She is also a
former Minister of Health of Botswana, former Professor of Nursing at the
University of Botswana and Director of the WHO Collaborating Centre for
Nursing and Midwifery Development in Primary Health Care for Anglophone
Africa.

Professor James Buchan is an Adjunct Professor at the WHO Collaborating
Centre, University of Technology, Sydney, Australia and a Visiting Professor
at the University of Edinburgh. He is also Editor in Chief of the Human
Resources for Health Journal. He has extensive experience as a policymaker,
policy analyst and consultancy on health workforce and health systems,

Dr. J Carolyn Gomes, Vice-Chair of the Strategy Committee - The Global Fund
Board and Board Member of The Developing Country NGO Delegation to the GF
Board, has a distinguished record as a Human Rights advocate. A medical doctor
since 1980, Dr. Carolyn has worked in public and private medicine in Trinidad
and Jamaica until 2002 when she gave up practice to work full time on issues
related to human rights.

Dr. Peter Carter, An independent healthcare consultant and former CEO of the
Royal College of Nursing, Dr. Peter Carter comes with a diverse experience. He
is a Fellow of the Royal College of Nursing, an honorary fellow of the Royal
College of General Practitioners, and an Ad Eundem of the Royal College of
Surgeons of Ireland. In 2011, he was awarded the inaugural Presidents medal of
the Royal College of Psychiatrists. In 2006, he was awarded the OBE by Her
Majesty Queen Elizabeth for his service to the NHS. Since leaving the RCN, he
has worked across the UK and internationally.

Dr. Niti Pall - Senior Digital Advisor for AXA (EC), Board Chair of Harbr and
Managing Director of Health4all advisory. Dr. Pall is a visionary senior
clinical leader, who has extensive prior experience in leading developmental
roles and has a passion for the delivery of top quality primary care to
disadvantaged communities. She has experience in scaling payer and provider
models both in the UK, India and many other emerging markets. She continues to
work as a clinician part-time in Birmingham, UK. She has worked in 44
countries.

ENDS

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service
providers operating in GCC and in India. With an inherent emphasis on clinical
excellence, we are one of the few entities in the world with a strong presence
across primary, secondary, tertiary, and quaternary healthcare through our 30
hospitals, 125 clinics, 496* pharmacies, 20 labs and 157 patient experience
centers in seven countries, including India. We have over 29,108 plus
dedicated staff including 3,820 doctors and 8,299 nurses across the
geographies that we are present in, delivering a simple yet strong promise to
our different stakeholders: "We'll treat you well." We reach out to all
economic segments in the GCC states through our differentiated healthcare
services across the "Aster", "Medcare" and "Access" brands.

* Including 239 Pharmacies in India operated by Alfaone Retail Pharmacies
Private Limited under brand license from Aster.

Aster has appointed Ernst & Young LLP (EY) as 'Process Advisors' for this
edition. EY will review the applications based on the defined eligibility
criteria, moderate shortlisting process of the entries by an independent panel
of experts and present a list of shortlisted finalists to the Grand Jury

For further information about us, please contact:

Charlotte Joseph / Markettiers

Tel: +971 (0)55 9418449

Email: charlotte@Markettiers4dc.com (mailto:charlotte@Markettiers4dc.com)

SOURCE: Aster DM Healthcare Limited

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASEMFFSEDSELD